GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Obalon Therapeutics Inc (NAS:OBLN) » Definitions » Profitability Rank

Obalon Therapeutics (Obalon Therapeutics) Profitability Rank : 0 (As of Mar. 2021)


View and export this data going back to 2016. Start your Free Trial

What is Obalon Therapeutics Profitability Rank?

Obalon Therapeutics has the Profitability Rank of 0.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

Obalon Therapeutics's Operating Margin % for the quarter that ended in Mar. 2021 was %. As of today, Obalon Therapeutics's Piotroski F-Score is 0.


Competitive Comparison of Obalon Therapeutics's Profitability Rank

For the Medical Devices subindustry, Obalon Therapeutics's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Obalon Therapeutics's Profitability Rank Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Obalon Therapeutics's Profitability Rank distribution charts can be found below:

* The bar in red indicates where Obalon Therapeutics's Profitability Rank falls into.



Obalon Therapeutics Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Obalon Therapeutics has the Profitability Rank of 0.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Obalon Therapeutics's Operating Margin % for the quarter that ended in Mar. 2021 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2021 ) / Revenue (Q: Mar. 2021 )
=-4.168 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Obalon Therapeutics has an F-score of 0. It is a bad or low score, which usually implies poor business operation.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

4. Consistency of the profitability

5. Predictability Rank


Obalon Therapeutics Profitability Rank Related Terms

Thank you for viewing the detailed overview of Obalon Therapeutics's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Obalon Therapeutics (Obalon Therapeutics) Business Description

Traded in Other Exchanges
N/A
Address
5421 Avenida Encinas, Suite F, Carlsbad, CA, USA, 92008
Obalon Therapeutics Inc is a medical device company that focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Its product includes Obalon Balloon System. Geographically, it derives all of its revenue from the United States.
Executives
Raymond V Dittamore director P O BOX 2050, GLENWOOD SPRINGS CO 81602
William J. Plovanic director C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD CA 92008
Sharon Stevenson director C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ECINAS, SUITE F, CARLSBAD CA 92008
Douglas Fisher director 587 PATROL RD, WOODSIDE CA 94062
Lesley H Howe director
Kim P. Kamdar director C/O DOMAIN ASSOCIATES, L.L.C., ONE PALMER SQUARE, SUITE 515, PRINCETON NJ 08542
Andrew P Rasdal director, officer: President, CEO & Exec Chairman C/O DEXCOM, INC., 5555 OBERLIN DRIVE, SAN DIEGO CA 92121
Nooshin Hussainy officer: Chief Financial Officer C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD CA 92008
Mark Brister officer: Chief Technology Officer C/O DEXCOM, INC., 5555 OBERLIN DRIVE, SAN DIEGO CA 92121
Robert J Macdonald officer: Chief Retail Officer C/O OBALON THERAPEUTICS INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD CA 92008
Amy Vandenberg officer: Chief Clinical & Reg Officer C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD CA 92008
Nicole Vitullo 10 percent owner 3030 SCIENCE PARK ROAD, SAN DIEGO CA 92121
Brian H Dovey 10 percent owner ONE PALMER SQUARE, PRINCETON NJ 08542
Arnold L Oronsky 10 percent owner C/O INTERWEST PARTNERS, 467 FIRST STREET SUITE 201, LOS ALTOS CA 94022
Gilbert H Kliman 10 percent owner C/O INTERWEST PARTNERS, 467 FIRST STREET SUITE 201, LOS ALTOS CA 94022

Obalon Therapeutics (Obalon Therapeutics) Headlines